Treatments

Research on mesothelioma treatments devoted to your prognosis. Inform yourself on the latest clinical trials and holistic treatments being used now.

Asia | International | Surgery | Treatments

Lung-Sparing Surgery for Mesothelioma Superior to EPP, Study Says
ByAlex Strauss July 12, 2020

A team of Japanese researchers have added their voices to the ongoing debate over lung-sparing surgery for mesothelioma. The researchers…

Read More Lung-Sparing Surgery for Mesothelioma Superior to EPP, Study Says
Diagnosis | New Studies | Research | Statistics | Treatments

Study Highlights Treatment Disparities in Female Mesothelioma Patients
ByAlex Strauss July 3, 2020

Female mesothelioma patients are less likely to have surgery and other aggressive treatments than male patients are, but they still…

Read More Study Highlights Treatment Disparities in Female Mesothelioma Patients
Chemotherapy | Multi-Modality Therapy | New Studies | Research | Surgery | Treatments

Long Term Peritoneal Mesothelioma Survival with NIPEC
ByAlex Strauss June 30, 2020June 30, 2020

A new report suggests that long term peritoneal mesothelioma survival may be possible with a treatment called NIPEC and the…

Read More Long Term Peritoneal Mesothelioma Survival with NIPEC
New Drugs | Treatments

FDA Approval of Keytruda will Help Some Mesothelioma Patients
ByAlex Strauss June 25, 2020

The FDA approval of Keytruda this month may help some patients in their battle against asbestos cancer. Keytruda is the…

Read More FDA Approval of Keytruda will Help Some Mesothelioma Patients
Diagnosis | New Techniques | Radiation Therapy | Treatments

Artificial Intelligence in Mesothelioma Diagnosis, Prognosis, and Treatment Planning
ByAlex Strauss June 23, 2020

Two newly-published studies highlight some of the ways that artificial intelligence may help with the diagnosis and treatment of malignant…

Read More Artificial Intelligence in Mesothelioma Diagnosis, Prognosis, and Treatment Planning
Chemotherapy | Europe | International | New Drugs | New Studies | Research | Treatments

Second-Line Mesothelioma Treatment with Ramucirumab
ByAlex Strauss June 21, 2020

A combination of ramucirumab (CYRAMZA) and gemcitabine creates a promising second-line mesothelioma treatment. New research shows the combination nearly doubled…

Read More Second-Line Mesothelioma Treatment with Ramucirumab
Chemotherapy | Immune Systems | Immunotherapy | Multi-Modality Therapy | Research | Treatments

Immunotherapy with Durvalumab: Record Survival in Inoperable Mesothelioma
ByAlex Strauss June 17, 2020

There is new evidence that the immunotherapy drug durvalumab may make chemotherapy more effective for people with inoperable pleural mesothelioma.…

Read More Immunotherapy with Durvalumab: Record Survival in Inoperable Mesothelioma
Chemotherapy | Radiation Therapy | Treatments

Chemoperfusion Treatment for Mesothelioma: Chemo Without the Side Effects?
ByAlex Strauss June 15, 2020

New research suggests that chemoperfusion treatment for mesothelioma may buy patients more time without the side effects of traditional chemotherapy. …

Read More Chemoperfusion Treatment for Mesothelioma: Chemo Without the Side Effects?
New Studies | Research | Surgery | Treatments

Black Mesothelioma Patients Less Likely to Receive Surgery
ByAlex Strauss June 13, 2020

Black mesothelioma patients are less likely to receive potentially-life saving surgery than white patients, even though they have worse short-term…

Read More Black Mesothelioma Patients Less Likely to Receive Surgery
Asia | International | Symptoms | Treatments | Updates

Pleural Effusion in Mesothelioma: Comparing Solutions
ByAlex Strauss June 11, 2020

A new study says, when it comes to pleural effusion in mesothelioma, the two main solutions are pretty equal –…

Read More Pleural Effusion in Mesothelioma: Comparing Solutions

1 (888) 378-1331

Treatments

Lung-Sparing Surgery for Mesothelioma Superior to EPP, Study Says

Study Highlights Treatment Disparities in Female Mesothelioma Patients

Long Term Peritoneal Mesothelioma Survival with NIPEC

FDA Approval of Keytruda will Help Some Mesothelioma Patients

Artificial Intelligence in Mesothelioma Diagnosis, Prognosis, and Treatment Planning

Second-Line Mesothelioma Treatment with Ramucirumab

Immunotherapy with Durvalumab: Record Survival in Inoperable Mesothelioma

Chemoperfusion Treatment for Mesothelioma: Chemo Without the Side Effects?

Black Mesothelioma Patients Less Likely to Receive Surgery

Pleural Effusion in Mesothelioma: Comparing Solutions

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES